Sign in

CIK 0001053369 · Non-accelerated filer<br>Smaller reporting company

ELITE PHARMACEUTICALS INC /NV/

Sign in to watch
Ticker
ELTP
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
NJ
Entity type
operating
EIN
223542636
Phone
2017502646
Business address
165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
Former names
ELITE PHARMACEUTICALS INC /DE/
  1. 4 Grant or award Director acquired 161,374 shares (grant or award)
  2. 4 Grant or award Director acquired 161,374 shares (grant or award)
  3. 4 Grant or award Director acquired 161,374 shares (grant or award)
  4. 4 Other disposition CEO & President disposed of 158,017,321 shares (other)
  5. 4 Grant or award Director acquired 72,040 shares (grant or award)
  6. 4 Grant or award Director acquired 68,518 shares (grant or award)
  7. 4 Grant or award SVP of Operations acquired 110,849 shares (grant or award)
  8. 4 Grant or award Director acquired 133,019 shares (grant or award)
  9. 4 Grant or award Director acquired 88,679 shares (grant or award)
  10. 4 Grant or award Director acquired 88,679 shares (grant or award)
  11. 4 Grant or award CEO & President acquired 2,216,992 shares (grant or award)
  12. 4 Option exercise CEO & President acquired 142,857,143 shares (option exercise)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Conversion CFO, Secretary, Treasurer acquired 666,667 shares (conversion)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Conversion Former Director acquired 4,000,000 shares (conversion)
  17. 4 Open-market sale former Chairman sold 570,520 shares at an average $0.34 ($196,055)
  18. 4 Open-market sale former Chairman sold 200,456 shares at an average $0.32 ($63,231)
  19. 4 Open-market sale former Chairman sold 909,878 shares at an average $0.33 ($301,266)
  20. 4 Grant or award Exec Vice Pres Operations acquired 47,767 shares (grant or award)

Page 3 of 26 · 511 filings